Evoked potentials in evaluation of solcoseryl (actihamly)















EUROPEAN fEDERATION Of NEUROLOGICAL SOCIETIES C'N-S ! 
June 15 .. 18, 2005 
Pula, Croatia 
VOL 54 SUPPL 2 2005NEUROL CROAT 
South East European Society for Neurology and Psychiatry 

INTERNATIONAL NEUROPSYCHIATRIC PULA SYMPOSIA 

B. Barac, Zagreb 
L. Battistin, Padov. 
E. Dimitriou. Thessaloniki' 
D. Fontanari. Venezia 
F. Gerstenbrand. Vienna 
G. Gross, Bonn 
"ex officio 
Z. Ambler, Pilsen 
V. Brinar, Zagreb 
L. Deeeke. Vienna 
V. Demarin, Zagreb 
R. Erkwoh. Aachen 
R. Fahlbusch, Erlangen 
V. Folnegovle Smale, Zagreb 
Lj. Hotujae. Zagreb 
Bosko Barac, Zagreb 
(INPS) 
In cooperation with 
Croatian Medical Association 
www.!lula-sym!M~om 
KURATORIllM: 
BOAR!) OF TRUSTEES 
G. Huber, Bonn 

Ch. lerodiakonou. Thessaloniki ' 

J Kugler, Munehen 

G. Lanner, Klagenfurt 
H. Lechner. Graz 
Z. Levie. Beograd 

V Muacevlc. Zagreb 

SCIENTIFIC AIWISORY BOAR!) 
H. Katschnig, Vienna 
J. KlosterkOtter, Cologne 

!let Koemur. Ljubljana 

Z. Lackovic, Zagreb 
S. Loga, Sarajevo 
N. Mandie, Osijek 

Lj. Moro. Rijeka 

G. Ocic. Beograd 
SECRETARIES GENERAL: 
lIelmut Lechner, Graz 
B. Neund6rfer, Erlangen 
N. Persic, Zagreb 
T. Pogacnik, Ljubljana 
T. S. Prevee, Ljubljana 
A. Rados, Pula 
N. Rizzuto, Verona 
D. B. Vodusek, Ljubljana 
V. R. Paunovic, Beograd 
B. Riechling. Salzburg 
E. Rumpl, Klagenfurt 
II. Sass, Aachen 
o. Sinanovic, Tuzla 
L ToresinL Portogruaro 
M Wender, Poznan 
K. Wilheim, Rijeka 
Aldo Rados, Pula 
Bosko Barac, MD, Dr Med Sc. Professor em. of Neurology, Schools of Medicine, lJniversities of Zagreb and Osijek 
Academy of Medical Sciences of Croatia. American Academy of Neurology (lIon. Member). 
American Neurological Association. Coordinating Editor, Proceedings INPS. 
Address ofZagreb Secretariat: Prof Bosko Barac, MD, Dr Med Sc, Pantovcak 102, H R-l 0000 Zagreb, Croatia 
Tel & FAX: + 385 1 4822297 E-mail: bosko,barac@zg,hinet.hr 
Address ofGraz Secretariat: Prof DDr h c Helmut Lechner, Institut fur Klinische Neurophysiologie 
Humboldtstr.47, A 8010 Graz, Austria Tel,: +43316323312 FAX: +43316383510 
Dr. Liljana Ilievska, Skopje 
Zagreb, Mart 19,2006 
Dear Dr I1ievska, 
We thank you submitting your very interesting paper: 
L I1ievska, E lIievska (Skopje): 
EVOKED POTENTIALS IN EVALUATION OF SOLCOSERYL 
(ACTIHAMYL) EFECTS IN THE TREATMENT OF CEREBRAL 
ATROPHIC PROCESSIES 
for presentation in the Program of the 46th International Neuropsychiatric Pula Symposium. 
1 am glad to confinn, that the paper has been reviewed and accepted for publication in the 
Proceedings and for presentation in the PROGRAM of our Symposium. Your paper has to be 
presented at the Thursday, June 17,2006, 15:00 - 16:00. 
The relevant information on the Oral presentation you can find on our Web Site: 
www.pula-symp.com 
Kind regards, looking forward to see you in Pula! 
Yours sincerely, 
Bosko Sarac, Secretary GenerallNPS, 
Coordinating Editor of the INPS "Proceedings" 
EVOKED POTEN'IIIi\LS IN I;:VALUATIO;,\ OF SOLCOSERYL {ACT[IIA~YL) 
EFECTS IN THE TREATMYNT OF CEREBRAL ATROl)HIC PROCESSES 
L. Jlievska, E. Ilievsk 
Clinic of NeUl'olog~, en,1 k~ll Ct~n!:rc, Skop,je, H.. fvl::..cedonia 
Twenty-five patients \\ Ill! C!:~rebrcli JtrophlC processes, either lo,~al or diffuse, of variou:­
etiology. provt~d by ()1:1IHlterizl~d lornography were investigated and treated. Elewn 
patiens. beside other ~;:';lPJ'Il1S. al:;\l had \;~pilept\c :'eizures. The younge'st patient was 43­
year-old, the oldest 62 \vilh mean :lge of 59 ) ears. 
All patients underwer· p:-\chologil.: t{!sting priqr to and after therapy with Actiham yI 
(Solcoseryl). and the i';'"U!is s!lol.v.:d difthenl degrees ~)I' Plental tllnclion deficits, Abo. 
LEG and evoked POll!lli i visual and sOlllatos(:n';ory) recordings v,ere made in several 
instances, shO\ving to (P.· II good ir«icalor in;)bjac'.:tivization of the /\ctihamyl aclion Oil 
cerebral metaholism. 
Concerning the thcrap\" Ihe palien~~; adminish:l';ng this medication were divided into tVvt, 
groups: 
The tirst one (161" lit'lIb) adlllill:;it.;:rcd mnp. Aclihamyl wilhin a period of:,ix weeks 
and 
The socond one l{} (;"ll~i1S) whe were eX;;lrnined by mean~. of EVP after Lv. injection 
of Acti ham iL \vilc!, Ii',> ,I ;:'ute ~·r'::;:t \Vas tesled. 
The contol group cOIl:i:.,{,:d of III patients with no neurologic disease, adminsiterin,:,! 
placebo instead of a til' !)2 .lilcrc \',I:r,;: PO sub.:cc1jv(: or objf'ctin' effect:; shown by meall~ 
of EECis and EVPs n:t. nrr.ii Il "., 
